Fortis, Spyridon <br/><br/>
Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.  [electronic resource] 

 -  Annals of the American Thoracic Society  07 2019 
 - 826-835 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2325-6621 
<br/><br/><label>Standard No.: </label>10.1513/AnnalsATS.201809-601OC  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Asthma--diagnosis<br/>Bronchodilator Agents--therapeutic use<br/>Cohort Studies<br/>Disease Progression<br/>Female<br/>Forced Expiratory Volume--physiology<br/>Humans<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Proportional Hazards Models<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Respiratory Function Tests<br/>Retrospective Studies<br/>Risk Assessment<br/>Severity of Illness Index<br/>Spirometry--methods<br/>Survival Analysis<br/>Tomography, X-Ray Computed--methods<br/>Treatment Outcome<br/>Vital Capacity--physiology